Clinical Trial Update: Study To Assess Frequency Of Serious Infections In Clinical Practice In Japan For Adult Participants With Rheumatoid Arthritis Receiving Oral RINVOQ Tablets

View source ↗

Summary

A real-world study in Japan assessed the frequency of serious infections among adults with rheumatoid arthritis receiving Rinvoq (upadacitinib); the study has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• RINVOQ (Upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Rheumatoid Arthritis (RA) | Status: COMPLETED